Institutional Ownership
Titan Pharmaceuticals Inc De
CUSIP 888314705COM NEWTTNPUSDQ1 2026
Earnings
Quarterly EPS and revenue are sourced from SEC XBRL financial statements. We ingest the top issuers first; this fills in as coverage expands (or this security isn't mapped to an SEC filer yet).